{
    "abstract": "Non-typeable Haemophilus influenzae (NTHi) and Moraxella catarrhalis (Mcat) are frequent pathogens in acute exacerbations of COPD. We assessed the safety, reactogenicity and immunogenicity of different investigational vaccine formulations containing surface proteins of NTHi (PD and PE-PilA) and Mcat (UspA2) in adults with smoking history \u226510 pack-years, to immunologically represent the COPD population. Participants received two doses 60 days apart in a randomised, observer-blind, placebo-controlled study (NCT02547974). In step 1, 30 healthy adults aged 18\u201340 years were randomised (1:1) to receive a non-adjuvanted formulation (10-10-PLAIN) or placebo. In step 2, 90 smokers/ex-smokers aged 50\u201370 years randomly (1:1:1) received an AS01-adjuvanted formulation containing either 10 \u00b5g of each antigen (10-10-AS01) or 10 \u00b5g of each NTHi antigen and 3.3 \u00b5g of Mcat antigen (10-3-AS01), or placebo. Incidences of solicited local adverse events (AEs) tended to be highest in the AS01-adjuvanted vaccine groups. Most solicited AEs had mild/moderate intensity. No vaccine-related serious AEs were reported. The 10-3-AS01 formulation induced the best humoral immune response against the NTHi antigens. Responses against the Mcat antigen were similar across groups, with waning immunogenicity after 30 days post-dose 2. The investigational NTHi-Mcat vaccine had an acceptable safety and reactogenicity profile and good immunogenicity in older adults with a smoking history.",
    "author_highlights": [
        {
            "endOffset": 14874,
            "sentence": "The combined NTHi-Mcat vaccine had an acceptable safety and reactogenicity profile.",
            "startOffset": 14791
        },
        {
            "endOffset": 14958,
            "sentence": "Most reactions were mild/moderate and resolved within a few days after vaccination.",
            "startOffset": 14875
        },
        {
            "endOffset": 15029,
            "sentence": "Reactogenicity was highest in the adjuvanted NTHi-Mcat vaccine groups.",
            "startOffset": 14959
        },
        {
            "endOffset": 15113,
            "sentence": "The protein vaccine had good immunogenicity in older adults with a smoking history.",
            "startOffset": 15030
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Davies",
                    "initial": "D.",
                    "last": "Adeloye"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Chua"
                },
                {
                    "first": "Chinwei",
                    "initial": "C.",
                    "last": "Lee"
                },
                {
                    "first": "Catriona",
                    "initial": "C.",
                    "last": "Basquill"
                },
                {
                    "first": "Angeliki",
                    "initial": "A.",
                    "last": "Papana"
                },
                {
                    "first": "Evropi",
                    "initial": "E.",
                    "last": "Theodoratou"
                },
                {
                    "first": "Harish",
                    "initial": "H.",
                    "last": "Nair"
                },
                {
                    "first": "Danijela",
                    "initial": "D.",
                    "last": "Gasevic"
                },
                {
                    "first": "Devi",
                    "initial": "D.",
                    "last": "Sridhar"
                },
                {
                    "first": "Harry",
                    "initial": "H.",
                    "last": "Campbell"
                },
                {
                    "first": "Kit Yee",
                    "initial": "K.Y.",
                    "last": "Chan"
                },
                {
                    "first": "Aziz",
                    "initial": "A.",
                    "last": "Sheikh"
                },
                {
                    "first": "Igor",
                    "initial": "I.",
                    "last": "Rudan"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.7189/jogh.05.020415",
            "issn": "20472978",
            "pmid": "26755942",
            "pub_year": 2015,
            "title": "Global and regional estimates of COPD prevalence: Systematic review and meta-analysis",
            "volume": "5"
        },
        "b0010": {
            "authors": [
                {
                    "first": "A. Sonia",
                    "initial": "A.S.",
                    "last": "Buist"
                },
                {
                    "first": "Mary Ann",
                    "initial": "M.A.",
                    "last": "McBurnie"
                },
                {
                    "first": "William M.",
                    "initial": "W.M.",
                    "last": "Vollmer"
                },
                {
                    "first": "Suzanne",
                    "initial": "S.",
                    "last": "Gillespie"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Burney"
                },
                {
                    "first": "David M.",
                    "initial": "D.M.",
                    "last": "Mannino"
                },
                {
                    "first": "Ana MB",
                    "initial": "A.M.",
                    "last": "Menezes"
                },
                {
                    "first": "Sean D.",
                    "initial": "S.D.",
                    "last": "Sullivan"
                },
                {
                    "first": "Todd A.",
                    "initial": "T.A.",
                    "last": "Lee"
                },
                {
                    "first": "Kevin B.",
                    "initial": "K.B.",
                    "last": "Weiss"
                },
                {
                    "first": "Robert L.",
                    "initial": "R.L.",
                    "last": "Jensen"
                },
                {
                    "first": "Guy B.",
                    "initial": "G.B.",
                    "last": "Marks"
                },
                {
                    "first": "Amund",
                    "initial": "A.",
                    "last": "Gulsvik"
                },
                {
                    "first": "Ewa",
                    "initial": "E.",
                    "last": "Nizankowska-Mogilnicka"
                }
            ],
            "doi": "10.1016/S0140-6736(07)61377-4",
            "firstpage": "741",
            "issn": "01406736",
            "lastpage": "750",
            "pmid": "17765523",
            "pub_year": 2007,
            "title": "International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study",
            "volume": "370"
        },
        "b0015": null,
        "b0020": {
            "authors": [
                {
                    "first": "Alex J.",
                    "initial": "A.J.",
                    "last": "Mackay"
                },
                {
                    "first": "John R.",
                    "initial": "J.R.",
                    "last": "Hurst"
                }
            ],
            "doi": "10.1016/j.iac.2012.10.006",
            "firstpage": "95",
            "issn": "08898561",
            "lastpage": "115",
            "pmid": "23337067",
            "pub_year": 2013,
            "title": "COPD Exacerbations. Causes, Prevention, and Treatment",
            "volume": "33"
        },
        "b0025": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Cazzola"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "MacNee"
                },
                {
                    "first": "F. J.",
                    "initial": "F.J.",
                    "last": "Martinez"
                },
                {
                    "first": "K. F.",
                    "initial": "K.F.",
                    "last": "Rabe"
                },
                {
                    "first": "L. G.",
                    "initial": "L.G.",
                    "last": "Franciosi"
                },
                {
                    "first": "P. J.",
                    "initial": "P.J.",
                    "last": "Barnes"
                },
                {
                    "first": "V.",
                    "initial": "V.",
                    "last": "Brusasco"
                },
                {
                    "first": "P. S.",
                    "initial": "P.S.",
                    "last": "Burge"
                },
                {
                    "first": "P. M.A.",
                    "initial": "P.M.A.",
                    "last": "Calverley"
                },
                {
                    "first": "B. R.",
                    "initial": "B.R.",
                    "last": "Celli"
                },
                {
                    "first": "P. W.",
                    "initial": "P.W.",
                    "last": "Jones"
                },
                {
                    "first": "D. A.",
                    "initial": "D.A.",
                    "last": "Mahler"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Make"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Miravitlles"
                },
                {
                    "first": "C. P.",
                    "initial": "C.P.",
                    "last": "Page"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Palange"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Parr"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Pistolesi"
                },
                {
                    "first": "S. I.",
                    "initial": "S.I.",
                    "last": "Rennard"
                },
                {
                    "first": "M. P.",
                    "initial": "M.P.",
                    "last": "Rutten-van M\u00f6lken"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Stockley"
                },
                {
                    "first": "S. D.",
                    "initial": "S.D.",
                    "last": "Sullivan"
                },
                {
                    "first": "J. A.",
                    "initial": "J.A.",
                    "last": "Wedzicha"
                },
                {
                    "first": "E. F.",
                    "initial": "E.F.",
                    "last": "Wouters"
                }
            ],
            "doi": "10.1183/09031936.00099306",
            "firstpage": "416",
            "issn": "09031936",
            "lastpage": "468",
            "pmid": "18238951",
            "pub_year": 2008,
            "title": "Outcomes for COPD pharmacological trials: From lung function to biomarkers",
            "volume": "31"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Sanjay",
                    "initial": "S.",
                    "last": "Sethi"
                },
                {
                    "first": "Nancy",
                    "initial": "N.",
                    "last": "Evans"
                },
                {
                    "first": "Brydon J.B.",
                    "initial": "B.J.B.",
                    "last": "Grant"
                },
                {
                    "first": "Timothy F.",
                    "initial": "T.F.",
                    "last": "Murphy"
                }
            ],
            "doi": "10.1056/NEJMoa012561",
            "firstpage": "465",
            "issn": "00284793",
            "lastpage": "471",
            "pmid": "12181400",
            "pub_year": 2002,
            "title": "New strains of bacteria and exacerbations of chronic obstructive pulmonary disease",
            "volume": "347"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Tom M.A.",
                    "initial": "T.M.A.",
                    "last": "Wilkinson"
                },
                {
                    "first": "Emmanuel",
                    "initial": "E.",
                    "last": "Aris"
                },
                {
                    "first": "Simon",
                    "initial": "S.",
                    "last": "Bourne"
                },
                {
                    "first": "Stuart C.",
                    "initial": "S.C.",
                    "last": "Clarke"
                },
                {
                    "first": "Mathieu",
                    "initial": "M.",
                    "last": "Peeters"
                },
                {
                    "first": "Thierry G.",
                    "initial": "T.G.",
                    "last": "Pascal"
                },
                {
                    "first": "Sonia",
                    "initial": "S.",
                    "last": "Schoonbroodt"
                },
                {
                    "first": "Andrew C.",
                    "initial": "A.C.",
                    "last": "Tuck"
                },
                {
                    "first": "Viktoriya",
                    "initial": "V.",
                    "last": "Kim"
                },
                {
                    "first": "Kristoffer",
                    "initial": "K.",
                    "last": "Ostridge"
                },
                {
                    "first": "Karl J.",
                    "initial": "K.J.",
                    "last": "Staples"
                },
                {
                    "first": "Nicholas",
                    "initial": "N.",
                    "last": "Williams"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Williams"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Wootton"
                },
                {
                    "first": "Jeanne Marie",
                    "initial": "J.M.",
                    "last": "Devaster"
                }
            ],
            "doi": "10.1136/thoraxjnl-2016-209023",
            "issn": "00406376",
            "pmid": "28432209",
            "pub_year": 2017,
            "title": "A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD"
        },
        "b0040": {
            "authors": [
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Mayhew"
                },
                {
                    "first": "Nathalie",
                    "initial": "N.",
                    "last": "Devos"
                },
                {
                    "first": "Christophe",
                    "initial": "C.",
                    "last": "Lambert"
                },
                {
                    "first": "James R.",
                    "initial": "J.R.",
                    "last": "Brown"
                },
                {
                    "first": "Stuart C.",
                    "initial": "S.C.",
                    "last": "Clarke"
                },
                {
                    "first": "Viktoriya L.",
                    "initial": "V.L.",
                    "last": "Kim"
                },
                {
                    "first": "Michal",
                    "initial": "M.",
                    "last": "Magid-Slav"
                },
                {
                    "first": "Bruce E.",
                    "initial": "B.E.",
                    "last": "Miller"
                },
                {
                    "first": "Kristoffer K.",
                    "initial": "K.K.",
                    "last": "Ostridge"
                },
                {
                    "first": "Ruchi",
                    "initial": "R.",
                    "last": "Patel"
                },
                {
                    "first": "Ganesh",
                    "initial": "G.",
                    "last": "Sathe"
                },
                {
                    "first": "Daniel F.",
                    "initial": "D.F.",
                    "last": "Simola"
                },
                {
                    "first": "Karl J.",
                    "initial": "K.J.",
                    "last": "Staples"
                },
                {
                    "first": "Ruby",
                    "initial": "R.",
                    "last": "Sung"
                },
                {
                    "first": "Ruth",
                    "initial": "R.",
                    "last": "Tal-Singer"
                },
                {
                    "first": "Andrew C.",
                    "initial": "A.C.",
                    "last": "Tuck"
                },
                {
                    "first": "Stephanie",
                    "initial": "S.",
                    "last": "Van Horn"
                },
                {
                    "first": "Vincent",
                    "initial": "V.",
                    "last": "Weynants"
                },
                {
                    "first": "Nicholas P.",
                    "initial": "N.P.",
                    "last": "Williams"
                },
                {
                    "first": "Jeanne Marie",
                    "initial": "J.M.",
                    "last": "Devaster"
                },
                {
                    "first": "Tom M.A.",
                    "initial": "T.M.A.",
                    "last": "Wilkinson"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1136/thoraxjnl-2017-210408",
            "firstpage": "422",
            "issn": "14683296",
            "lastpage": "430",
            "pmid": "29386298",
            "pub_year": 2018,
            "title": "Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations",
            "volume": "73"
        },
        "b0045": {
            "authors": [
                {
                    "first": "Yvonne J.",
                    "initial": "Y.J.",
                    "last": "Huang"
                },
                {
                    "first": "John R.",
                    "initial": "J.R.",
                    "last": "Erb-Downward"
                },
                {
                    "first": "Robert P.",
                    "initial": "R.P.",
                    "last": "Dickson"
                },
                {
                    "first": "Jeffrey L.",
                    "initial": "J.L.",
                    "last": "Curtis"
                },
                {
                    "first": "Gary B.",
                    "initial": "G.B.",
                    "last": "Huffnagle"
                },
                {
                    "first": "Mei Lan K.",
                    "initial": "M.L.K.",
                    "last": "Han"
                }
            ],
            "doi": "10.1016/j.trsl.2016.06.007",
            "firstpage": "71",
            "issn": "19315244",
            "lastpage": "83",
            "pmid": "27392936",
            "pub_year": 2017,
            "title": "Understanding the role of the microbiome in chronic obstructive pulmonary disease: principles, challenges, and future directions",
            "volume": "179"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Filipe",
                    "initial": "F.",
                    "last": "Froes"
                },
                {
                    "first": "Nicolas",
                    "initial": "N.",
                    "last": "Roche"
                },
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Blasi"
                }
            ],
            "doi": "10.2147/COPD.S140378",
            "firstpage": "3457",
            "issn": "11769106",
            "lastpage": "3468",
            "pmid": "29255353",
            "pub_year": 2017,
            "title": "Pneumococcal vaccination and chronic respiratory diseases",
            "volume": "12"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Antonia C.",
                    "initial": "A.C.",
                    "last": "Perez"
                },
                {
                    "first": "Timothy F.",
                    "initial": "T.F.",
                    "last": "Murphy"
                }
            ],
            "doi": "10.1016/j.vaccine.2016.12.066",
            "firstpage": "5551",
            "issn": "0264410X",
            "lastpage": "5558",
            "pmid": "28185742",
            "pub_year": 2019,
            "title": "Potential impact of a Moraxella catarrhalis vaccine in COPD",
            "volume": "37"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Tong Tan",
                    "initial": "T.T.",
                    "last": "Thuan"
                },
                {
                    "first": "Matthias",
                    "initial": "M.",
                    "last": "M\u00f6rgelin"
                },
                {
                    "first": "Arne",
                    "initial": "A.",
                    "last": "Forsgren"
                },
                {
                    "first": "Kristian",
                    "initial": "K.",
                    "last": "Riesbeck"
                }
            ],
            "doi": "10.1086/517611",
            "firstpage": "1661",
            "issn": "00221899",
            "lastpage": "1670",
            "pmid": "17471436",
            "pub_year": 2007,
            "title": "Haemophilus influenzae survival during complement-mediated attacks is promoted by Moraxella catarrhalis outer membrane vesicles",
            "volume": "195"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Chelsie E.",
                    "initial": "C.E.",
                    "last": "Armbruster"
                },
                {
                    "first": "Wenzhou",
                    "initial": "W.",
                    "last": "Hong"
                },
                {
                    "first": "Bing",
                    "initial": "B.",
                    "last": "Pang"
                },
                {
                    "first": "Kristin E.D.",
                    "initial": "K.E.D.",
                    "last": "Weimer"
                },
                {
                    "first": "Richard A.",
                    "initial": "R.A.",
                    "last": "Juneau"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Turner"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Edward Swords"
                }
            ],
            "doi": "10.1128/mBio.00102-10",
            "issn": "21507511",
            "pmid": "20802829",
            "pub_year": 2010,
            "title": "Indirect pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in Polymicrobial Otitis media occurs via interspecies quorum signaling",
            "volume": "1"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Viveka",
                    "initial": "V.",
                    "last": "Schaar"
                },
                {
                    "first": "Ther\u00e9se",
                    "initial": "T.",
                    "last": "Nordstr\u00f6m"
                },
                {
                    "first": "Matthias",
                    "initial": "M.",
                    "last": "M\u00f6rgelin"
                },
                {
                    "first": "Kristian",
                    "initial": "K.",
                    "last": "Riesbeck"
                }
            ],
            "doi": "10.1128/AAC.01772-10",
            "firstpage": "3845",
            "issn": "00664804",
            "lastpage": "3853",
            "pmid": "21576428",
            "pub_year": 2011,
            "title": "Moraxella catarrhalis outer membrane vesicles carry \u03b2-lactamase and promote survival of Streptococcus pneumoniae and Haemophilus influenzae by inactivating amoxicillin",
            "volume": "55"
        },
        "b0075": {
            "authors": [
                {
                    "first": "Arne",
                    "initial": "A.",
                    "last": "Forsgren"
                },
                {
                    "first": "Kristian",
                    "initial": "K.",
                    "last": "Riesbeck"
                },
                {
                    "first": "H\u00e5kan",
                    "initial": "H.",
                    "last": "Janson"
                }
            ],
            "doi": "10.1086/527396",
            "firstpage": "726",
            "issn": "10584838",
            "lastpage": "731",
            "pmid": "18230042",
            "pub_year": 2008,
            "title": "Protein D of Haemophilus influenzae: A protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines",
            "volume": "46"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Birendra",
                    "initial": "B.",
                    "last": "Singh"
                },
                {
                    "first": "Tamim",
                    "initial": "T.",
                    "last": "Al-Jubair"
                },
                {
                    "first": "Matthias",
                    "initial": "M.",
                    "last": "M\u00f6rgelin"
                },
                {
                    "first": "Marjolein M.",
                    "initial": "M.M.",
                    "last": "Thunnissen"
                },
                {
                    "first": "Kristian",
                    "initial": "K.",
                    "last": "Riesbeck"
                }
            ],
            "doi": "10.1128/IAI.01111-12",
            "firstpage": "801",
            "issn": "00199567",
            "lastpage": "814",
            "pmid": "23275089",
            "pub_year": 2013,
            "title": "The unique structure of haemophilus influenzae protein E reveals multiple binding sites for host factors",
            "volume": "81"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Teresia",
                    "initial": "T.",
                    "last": "Hallstr\u00f6m"
                },
                {
                    "first": "Anna M.",
                    "initial": "A.M.",
                    "last": "Blom"
                },
                {
                    "first": "Peter F.",
                    "initial": "P.F.",
                    "last": "Zipfel"
                },
                {
                    "first": "Kristian",
                    "initial": "K.",
                    "last": "Riesbeck"
                }
            ],
            "doi": "10.4049/jimmunol.0803226",
            "firstpage": "2593",
            "issn": "00221767",
            "lastpage": "2601",
            "pmid": "19635912",
            "pub_year": 2009,
            "title": "Nontypeable Haemophilus influenzae protein E binds vitronectin and is important for serum resistance",
            "volume": "183"
        },
        "b0090": {
            "authors": [
                {
                    "first": "Birendra",
                    "initial": "B.",
                    "last": "Singh"
                },
                {
                    "first": "Farshid",
                    "initial": "F.",
                    "last": "Jalalvand"
                },
                {
                    "first": "Matthias",
                    "initial": "M.",
                    "last": "M\u00f6rgelin"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Zipfel"
                },
                {
                    "first": "Anna M.",
                    "initial": "A.M.",
                    "last": "Blom"
                },
                {
                    "first": "Kristian",
                    "initial": "K.",
                    "last": "Riesbeck"
                }
            ],
            "doi": "10.1111/j.1365-2958.2011.07678.x",
            "firstpage": "80",
            "issn": "0950382X",
            "lastpage": "98",
            "pmid": "21542857",
            "pub_year": 2011,
            "title": "Haemophilus influenzae protein E recognizes the C-terminal domain of vitronectin and modulates the membrane attack complex",
            "volume": "81"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Joseph A.",
                    "initial": "J.A.",
                    "last": "Jurcisek"
                },
                {
                    "first": "James E.",
                    "initial": "J.E.",
                    "last": "Bookwalter"
                },
                {
                    "first": "Beth D.",
                    "initial": "B.D.",
                    "last": "Baker"
                },
                {
                    "first": "Soledad",
                    "initial": "S.",
                    "last": "Fernandez"
                },
                {
                    "first": "Laura A.",
                    "initial": "L.A.",
                    "last": "Novotny"
                },
                {
                    "first": "Robert S.",
                    "initial": "R.S.",
                    "last": "Munson"
                },
                {
                    "first": "Lauren O.",
                    "initial": "L.O.",
                    "last": "Bakaletz"
                }
            ],
            "doi": "10.1111/j.1365-2958.2007.05864.x",
            "firstpage": "1288",
            "issn": "0950382X",
            "lastpage": "1299",
            "pmid": "17645732",
            "pub_year": 2007,
            "title": "The PilA protein of non-typeable Haemophilus influenzae plays a role in biofilm formation, adherence to epithelial cells and colonization of the mammalian upper respiratory tract",
            "volume": "65"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Ahmed S.",
                    "initial": "A.S.",
                    "last": "Attia"
                },
                {
                    "first": "Eric R.",
                    "initial": "E.R.",
                    "last": "Lafontaine"
                },
                {
                    "first": "Jo L.",
                    "initial": "J.L.",
                    "last": "Latimer"
                },
                {
                    "first": "Christoph",
                    "initial": "C.",
                    "last": "Aebi"
                },
                {
                    "first": "George A.",
                    "initial": "G.A.",
                    "last": "Syrogiannopoulos"
                },
                {
                    "first": "Eric J.",
                    "initial": "E.J.",
                    "last": "Hansen"
                }
            ],
            "doi": "10.1128/IAI.73.4.2400-2410.2005",
            "firstpage": "2400",
            "issn": "00199567",
            "lastpage": "2410",
            "pmid": "15784586",
            "pub_year": 2005,
            "title": "The UspA2 protein of Moraxella catarrhalis is directly involved in the expression of serum resistance",
            "volume": "73"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Ahmed S.",
                    "initial": "A.S.",
                    "last": "Attia"
                },
                {
                    "first": "Sanjay",
                    "initial": "S.",
                    "last": "Ram"
                },
                {
                    "first": "Peter A.",
                    "initial": "P.A.",
                    "last": "Rice"
                },
                {
                    "first": "Eric J.",
                    "initial": "E.J.",
                    "last": "Hansen"
                }
            ],
            "doi": "10.1128/IAI.74.3.1597-1611.2006",
            "firstpage": "1597",
            "issn": "00199567",
            "lastpage": "1611",
            "pmid": "16495531",
            "pub_year": 2006,
            "title": "Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade",
            "volume": "74"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Eric R.",
                    "initial": "E.R.",
                    "last": "Lafontaine"
                },
                {
                    "first": "Leslie D.",
                    "initial": "L.D.",
                    "last": "Cope"
                },
                {
                    "first": "Christoph",
                    "initial": "C.",
                    "last": "Aebi"
                },
                {
                    "first": "Jo L.",
                    "initial": "J.L.",
                    "last": "Latimer"
                },
                {
                    "first": "George H.",
                    "initial": "G.H.",
                    "last": "McCracken"
                },
                {
                    "first": "Eric J.",
                    "initial": "E.J.",
                    "last": "Hansen"
                }
            ],
            "doi": "10.1128/JB.182.5.1364-1373.2000",
            "firstpage": "1364",
            "issn": "00219193",
            "lastpage": "1373",
            "pmid": "10671460",
            "pub_year": 2000,
            "title": "The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro",
            "volume": "182"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Dexiang",
                    "initial": "D.",
                    "last": "Chen"
                },
                {
                    "first": "John C.",
                    "initial": "J.C.",
                    "last": "Mcmichael"
                },
                {
                    "first": "Karl R.",
                    "initial": "K.R.",
                    "last": "Vandermeid"
                },
                {
                    "first": "Denise",
                    "initial": "D.",
                    "last": "Hahn"
                },
                {
                    "first": "Terri",
                    "initial": "T.",
                    "last": "Mininni"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Cowell"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Eldridge"
                }
            ],
            "firstpage": "1900",
            "issn": "00199567",
            "lastpage": "1905",
            "pmid": "8675285",
            "pub_year": 1996,
            "title": "Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization",
            "volume": "64"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Geert",
                    "initial": "G.",
                    "last": "Leroux-Roels"
                },
                {
                    "first": "Pierre",
                    "initial": "P.",
                    "last": "Van Damme"
                },
                {
                    "first": "Wouter",
                    "initial": "W.",
                    "last": "Haazen"
                },
                {
                    "first": "Sepehr",
                    "initial": "S.",
                    "last": "Shakib"
                },
                {
                    "first": "Magalie",
                    "initial": "M.",
                    "last": "Caubet"
                },
                {
                    "first": "Emmanuel",
                    "initial": "E.",
                    "last": "Aris"
                },
                {
                    "first": "Jeanne Marie",
                    "initial": "J.M.",
                    "last": "Devaster"
                },
                {
                    "first": "Mathieu",
                    "initial": "M.",
                    "last": "Peeters"
                }
            ],
            "doi": "10.1016/j.vaccine.2016.04.051",
            "firstpage": "3156",
            "issn": "0264410X",
            "lastpage": "3163",
            "pmid": "27133877",
            "pub_year": 2016,
            "title": "Phase I, randomized, observer-blind, placebo-controlled studies to evaluate the safety, reactogenicity and immunogenicity of an investigational non-typeable Haemophilus influenzae (NTHi) protein vaccine in adults",
            "volume": "34"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Arnaud M.",
                    "initial": "A.M.",
                    "last": "Didierlaurent"
                },
                {
                    "first": "B\u00e9atrice",
                    "initial": "B.",
                    "last": "Laup\u00e8ze"
                },
                {
                    "first": "Alberta",
                    "initial": "A.",
                    "last": "Di Pasquale"
                },
                {
                    "first": "Nadia",
                    "initial": "N.",
                    "last": "Hergli"
                },
                {
                    "first": "Catherine",
                    "initial": "C.",
                    "last": "Collignon"
                },
                {
                    "first": "Nathalie",
                    "initial": "N.",
                    "last": "Gar\u00e7on"
                }
            ],
            "doi": "10.1080/14760584.2016.1213632",
            "firstpage": "55",
            "issn": "14760584",
            "lastpage": "63",
            "pmid": "27448771",
            "pub_year": 2017,
            "title": "Adjuvant system AS01: helping to overcome the challenges of modern vaccines",
            "volume": "16"
        },
        "b0130": {
            "authors": [
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Barcel\u00f3"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Pons"
                },
                {
                    "first": "J. M.",
                    "initial": "J.M.",
                    "last": "Ferrer"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Sauleda"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Fuster"
                },
                {
                    "first": "A. G.N.",
                    "initial": "A.G.N.",
                    "last": "Agust\u00ed"
                }
            ],
            "doi": "10.1183/09031936.00010407",
            "firstpage": "555",
            "issn": "09031936",
            "lastpage": "562",
            "pmid": "18057064",
            "pub_year": 2008,
            "title": "Phenotypic characterisation of T-lymphocytes in COPD: Abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking",
            "volume": "31"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Daniel",
                    "initial": "D.",
                    "last": "Droemann"
                },
                {
                    "first": "Torsten",
                    "initial": "T.",
                    "last": "Goldmann"
                },
                {
                    "first": "Thorsten",
                    "initial": "T.",
                    "last": "Tiedje"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Zabel"
                },
                {
                    "first": "Klaus",
                    "initial": "K.",
                    "last": "Dalhoff"
                },
                {
                    "first": "Bernhard",
                    "initial": "B.",
                    "last": "Schaaf"
                }
            ],
            "doi": "10.1186/1465-9921-6-68",
            "issn": "1465993X",
            "pmid": "16004610",
            "pub_year": 2005,
            "title": "Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients",
            "volume": "6"
        },
        "b0140": {
            "authors": [
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Takanashi"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Hasegawa"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Kanehira"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Yamamoto"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Fujimoto"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Satoh"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Okamura"
                }
            ],
            "firstpage": "309",
            "issn": "09031936",
            "lastpage": "314",
            "pmid": "10515406",
            "pub_year": 1999,
            "title": "Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers",
            "volume": "14"
        },
        "b0145": {
            "authors": [
                {
                    "first": "Thuan Tong",
                    "initial": "T.T.",
                    "last": "Tan"
                },
                {
                    "first": "Jens J\u00f8rgen",
                    "initial": "J.J.",
                    "last": "Christensen"
                },
                {
                    "first": "Morten Hanefeld",
                    "initial": "M.H.",
                    "last": "Dziegiel"
                },
                {
                    "first": "Arne",
                    "initial": "A.",
                    "last": "Forsgren"
                },
                {
                    "first": "Kristian",
                    "initial": "K.",
                    "last": "Riesbeck"
                }
            ],
            "doi": "10.1128/IAI.00702-06",
            "firstpage": "6377",
            "issn": "00199567",
            "lastpage": "6386",
            "pmid": "16966403",
            "pub_year": 2006,
            "title": "Comparison of the serological responses to Moraxella catarrhalis immunoglobulin D-binding outer membrane protein and the ubiquitous surface proteins A1 and A2",
            "volume": "74"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Takao",
                    "initial": "T.",
                    "last": "Samukawa"
                },
                {
                    "first": "Noboru",
                    "initial": "N.",
                    "last": "Yamanaka"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Hollingshead"
                },
                {
                    "first": "Karin",
                    "initial": "K.",
                    "last": "Klingman"
                },
                {
                    "first": "Howard",
                    "initial": "H.",
                    "last": "Faden"
                }
            ],
            "doi": "10.1128/IAI.68.3.1569-1573.2000",
            "firstpage": "1569",
            "issn": "00199567",
            "lastpage": "1573",
            "pmid": "10678976",
            "pub_year": 2000,
            "title": "Immune responses to specific antigens of Streptococcus pneumoniae and Moraxella catarrhalis in the respiratory tract",
            "volume": "68"
        },
        "b0155": {
            "authors": [
                {
                    "first": "Fernanda",
                    "initial": "F.",
                    "last": "Tavares Da Silva"
                },
                {
                    "first": "Filip",
                    "initial": "F.",
                    "last": "De Keyser"
                },
                {
                    "first": "Paul Henri",
                    "initial": "P.H.",
                    "last": "Lambert"
                },
                {
                    "first": "William H.",
                    "initial": "W.H.",
                    "last": "Robinson"
                },
                {
                    "first": "Ren\u00e9",
                    "initial": "R.",
                    "last": "Westhovens"
                },
                {
                    "first": "Christian",
                    "initial": "C.",
                    "last": "Sindic"
                }
            ],
            "doi": "10.1016/j.vaccine.2013.01.042",
            "firstpage": "1870",
            "issn": "0264410X",
            "lastpage": "1876",
            "pmid": "23391600",
            "pub_year": 2013,
            "title": "Optimal approaches to data collection and analysis of potential immune mediated disorders in clinical trials of new vaccines",
            "volume": "31"
        },
        "b0160": null,
        "b0165": {
            "authors": [
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Moris"
                },
                {
                    "first": "Robbert",
                    "initial": "R.",
                    "last": "Van Der Most"
                },
                {
                    "first": "Isabel",
                    "initial": "I.",
                    "last": "Leroux-Roels"
                },
                {
                    "first": "Fr\u00e9d\u00e9ric",
                    "initial": "F.",
                    "last": "Clement"
                },
                {
                    "first": "Mamadou",
                    "initial": "M.",
                    "last": "Dram\u00e9"
                },
                {
                    "first": "Emmanuel",
                    "initial": "E.",
                    "last": "Hanon"
                },
                {
                    "first": "Geert G.",
                    "initial": "G.G.",
                    "last": "Leroux-Roels"
                },
                {
                    "first": "Marcelle",
                    "initial": "M.",
                    "last": "Van Mechelen"
                }
            ],
            "doi": "10.1007/s10875-010-9490-6",
            "firstpage": "443",
            "issn": "02719142",
            "lastpage": "454",
            "pmid": "21174144",
            "pub_year": 2011,
            "title": "H5N1 influenza vaccine formulated with AS03 A induces strong Cross-reactive and polyfunctional CD4 T-Cell responses",
            "volume": "31"
        },
        "b0170": {
            "authors": [
                {
                    "first": "Isabel",
                    "initial": "I.",
                    "last": "Leroux-Roels"
                },
                {
                    "first": "Jeanne Marie",
                    "initial": "J.M.",
                    "last": "Devaster"
                },
                {
                    "first": "Geert",
                    "initial": "G.",
                    "last": "Leroux-Roels"
                },
                {
                    "first": "Vincent",
                    "initial": "V.",
                    "last": "Verlant"
                },
                {
                    "first": "Isabelle",
                    "initial": "I.",
                    "last": "Henckaerts"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Moris"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Hermand"
                },
                {
                    "first": "Pascale",
                    "initial": "P.",
                    "last": "Van Belle"
                },
                {
                    "first": "Jan T.",
                    "initial": "J.T.",
                    "last": "Poolman"
                },
                {
                    "first": "Pierre",
                    "initial": "P.",
                    "last": "Vandepapeli\u00e8re"
                },
                {
                    "first": "Yves",
                    "initial": "Y.",
                    "last": "Horsmans"
                }
            ],
            "doi": "10.1016/j.vaccine.2013.10.052",
            "firstpage": "577",
            "issn": "0264410X",
            "lastpage": "584",
            "pmid": "24176494",
            "pub_year": 2015,
            "title": "Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: Randomised, controlled trials",
            "volume": "33"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Johan",
                    "initial": "J.",
                    "last": "Berglund"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Vink"
                },
                {
                    "first": "Fernanda Tavares",
                    "initial": "F.T.",
                    "last": "Da Silva"
                },
                {
                    "first": "Pascal",
                    "initial": "P.",
                    "last": "Lestrate"
                },
                {
                    "first": "Dominique",
                    "initial": "D.",
                    "last": "Boutriau"
                }
            ],
            "doi": "10.1128/CVI.00430-13",
            "firstpage": "56",
            "issn": "15566811",
            "lastpage": "65",
            "pmid": "24173029",
            "pub_year": 2014,
            "title": "Safety, immunogenicity, and antibody persistence following an investigational streptococcus pneumoniae and haemophilus influenzae triple-protein vaccine in a phase 1 randomized controlled study in healthy adults",
            "volume": "21"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Karlis",
                    "initial": "K.",
                    "last": "Pauksens"
                },
                {
                    "first": "Anna C.",
                    "initial": "A.C.",
                    "last": "Nilsson"
                },
                {
                    "first": "Magalie",
                    "initial": "M.",
                    "last": "Caubet"
                },
                {
                    "first": "Thierry G.",
                    "initial": "T.G.",
                    "last": "Pascal"
                },
                {
                    "first": "Pascale",
                    "initial": "P.",
                    "last": "Van Belle"
                },
                {
                    "first": "Jan T.",
                    "initial": "J.T.",
                    "last": "Poolman"
                },
                {
                    "first": "Pierre G.",
                    "initial": "P.G.",
                    "last": "Vandepapeli\u00e8re"
                },
                {
                    "first": "Vincent",
                    "initial": "V.",
                    "last": "Verlant"
                },
                {
                    "first": "Peter E.",
                    "initial": "P.E.",
                    "last": "Vink"
                }
            ],
            "doi": "10.1128/CVI.00807-13",
            "firstpage": "651",
            "issn": "15566811",
            "lastpage": "660",
            "pmid": "24599529",
            "pub_year": 2014,
            "title": "Randomized controlled study of the safety and immunogenicity of pneumococcal vaccine formulations containing PhtD and detoxified pneumolysin with alum or adjuvant system AS02Vin elderly adults",
            "volume": "21"
        },
        "b0185": {
            "authors": [
                {
                    "first": "Geert",
                    "initial": "G.",
                    "last": "Leroux-Roels"
                },
                {
                    "first": "Arnaud",
                    "initial": "A.",
                    "last": "Marchant"
                },
                {
                    "first": "Jack",
                    "initial": "J.",
                    "last": "Levy"
                },
                {
                    "first": "Pierre",
                    "initial": "P.",
                    "last": "Van Damme"
                },
                {
                    "first": "Tino F.",
                    "initial": "T.F.",
                    "last": "Schwarz"
                },
                {
                    "first": "Yves",
                    "initial": "Y.",
                    "last": "Horsmans"
                },
                {
                    "first": "Wolfgang",
                    "initial": "W.",
                    "last": "Jilg"
                },
                {
                    "first": "Peter G.",
                    "initial": "P.G.",
                    "last": "Kremsner"
                },
                {
                    "first": "Edwige",
                    "initial": "E.",
                    "last": "Haelterman"
                },
                {
                    "first": "Fr\u00e9d\u00e9ric",
                    "initial": "F.",
                    "last": "Cl\u00e9ment"
                },
                {
                    "first": "Julian J.",
                    "initial": "J.J.",
                    "last": "Gabor"
                },
                {
                    "first": "Meral",
                    "initial": "M.",
                    "last": "Esen"
                },
                {
                    "first": "Annick",
                    "initial": "A.",
                    "last": "Hens"
                },
                {
                    "first": "Isabelle",
                    "initial": "I.",
                    "last": "Carletti"
                },
                {
                    "first": "Laurence",
                    "initial": "L.",
                    "last": "Fissette"
                },
                {
                    "first": "Fernanda",
                    "initial": "F.",
                    "last": "Tavares Da Silva"
                },
                {
                    "first": "Wivine",
                    "initial": "W.",
                    "last": "Burny"
                },
                {
                    "first": "Michel",
                    "initial": "M.",
                    "last": "Janssens"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Moris"
                },
                {
                    "first": "Arnaud M.",
                    "initial": "A.M.",
                    "last": "Didierlaurent"
                },
                {
                    "first": "Robbert",
                    "initial": "R.",
                    "last": "Van Der Most"
                },
                {
                    "first": "Nathalie",
                    "initial": "N.",
                    "last": "Gar\u00e7on"
                },
                {
                    "first": "Pascale",
                    "initial": "P.",
                    "last": "Van Belle"
                },
                {
                    "first": "Marcelle",
                    "initial": "M.",
                    "last": "Van Mechelen"
                }
            ],
            "doi": "10.1016/j.clim.2016.05.007",
            "firstpage": "16",
            "issn": "15216616",
            "lastpage": "27",
            "pmid": "27236001",
            "pub_year": 2016,
            "title": "Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial",
            "volume": "169"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Dexiang",
                    "initial": "D.",
                    "last": "Chen"
                },
                {
                    "first": "Vicki",
                    "initial": "V.",
                    "last": "Barniak"
                },
                {
                    "first": "Karl R.",
                    "initial": "K.R.",
                    "last": "VanDerMeid"
                },
                {
                    "first": "John C.",
                    "initial": "J.C.",
                    "last": "McMichael"
                }
            ],
            "firstpage": "1310",
            "issn": "00199567",
            "lastpage": "1316",
            "pmid": "10024576",
            "pub_year": 1999,
            "title": "The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children",
            "volume": "67"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Alejandra",
                    "initial": "A.",
                    "last": "Pera"
                },
                {
                    "first": "Carmen",
                    "initial": "C.",
                    "last": "Campos"
                },
                {
                    "first": "Nelson",
                    "initial": "N.",
                    "last": "L\u00f3pez"
                },
                {
                    "first": "Fakhri",
                    "initial": "F.",
                    "last": "Hassouneh"
                },
                {
                    "first": "Corona",
                    "initial": "C.",
                    "last": "Alonso"
                },
                {
                    "first": "Raquel",
                    "initial": "R.",
                    "last": "Tarazona"
                },
                {
                    "first": "Rafael",
                    "initial": "R.",
                    "last": "Solana"
                }
            ],
            "doi": "10.1016/j.maturitas.2015.05.004",
            "firstpage": "50",
            "issn": "03785122",
            "lastpage": "55",
            "pmid": "26044074",
            "pub_year": 2015,
            "title": "Immunosenescence: Implications for response to infection and vaccination in older people",
            "volume": "82"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Kent E.",
                    "initial": "K.E.",
                    "last": "Kester"
                },
                {
                    "first": "James F.",
                    "initial": "J.F.",
                    "last": "Cummings"
                },
                {
                    "first": "Opokua",
                    "initial": "O.",
                    "last": "Ofori-Anyinam"
                },
                {
                    "first": "Christian F.",
                    "initial": "C.F.",
                    "last": "Ockenhouse"
                },
                {
                    "first": "Urszula",
                    "initial": "U.",
                    "last": "Krzych"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Moris"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Schwenk"
                },
                {
                    "first": "Robin A.",
                    "initial": "R.A.",
                    "last": "Nielsen"
                },
                {
                    "first": "Zufan",
                    "initial": "Z.",
                    "last": "Debebe"
                },
                {
                    "first": "Evgeny",
                    "initial": "E.",
                    "last": "Pinelis"
                },
                {
                    "first": "Laure",
                    "initial": "L.",
                    "last": "Juompan"
                },
                {
                    "first": "Jack",
                    "initial": "J.",
                    "last": "Williams"
                },
                {
                    "first": "Megan",
                    "initial": "M.",
                    "last": "Dowler"
                },
                {
                    "first": "V. Ann",
                    "initial": "V.A.",
                    "last": "Stewart"
                },
                {
                    "first": "Robert A.",
                    "initial": "R.A.",
                    "last": "Wirtz"
                },
                {
                    "first": "Marie Claude",
                    "initial": "M.C.",
                    "last": "Dubois"
                },
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "Lievens"
                },
                {
                    "first": "Joe",
                    "initial": "J.",
                    "last": "Cohen"
                },
                {
                    "first": "W. Ripley",
                    "initial": "W.R.",
                    "last": "Ballou"
                },
                {
                    "first": "D. Gray",
                    "initial": "D.G.",
                    "last": "Heppner"
                }
            ],
            "doi": "10.1086/600120",
            "firstpage": "337",
            "issn": "00221899",
            "lastpage": "346",
            "pmid": "19569965",
            "pub_year": 2009,
            "title": "Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: Safety, efficacy, and immunologic associates of protection",
            "volume": "200"
        },
        "b0205": {
            "authors": [
                {
                    "first": "Pierre",
                    "initial": "P.",
                    "last": "Vandepapeli\u00e8re"
                },
                {
                    "first": "Yves",
                    "initial": "Y.",
                    "last": "Horsmans"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Moris"
                },
                {
                    "first": "Marcelle",
                    "initial": "M.",
                    "last": "Van Mechelen"
                },
                {
                    "first": "Michel",
                    "initial": "M.",
                    "last": "Janssens"
                },
                {
                    "first": "Marguerite",
                    "initial": "M.",
                    "last": "Koutsoukos"
                },
                {
                    "first": "Pascale",
                    "initial": "P.",
                    "last": "Van Belle"
                },
                {
                    "first": "Fr\u00e9d\u00e9ric",
                    "initial": "F.",
                    "last": "Clement"
                },
                {
                    "first": "Emmanuel",
                    "initial": "E.",
                    "last": "Hanon"
                },
                {
                    "first": "Martine",
                    "initial": "M.",
                    "last": "Wettendorff"
                },
                {
                    "first": "Nathalie",
                    "initial": "N.",
                    "last": "Gar\u00e7on"
                },
                {
                    "first": "Geert",
                    "initial": "G.",
                    "last": "Leroux-Roels"
                }
            ],
            "doi": "10.1016/j.vaccine.2007.12.038",
            "firstpage": "1375",
            "issn": "0264410X",
            "lastpage": "1386",
            "pmid": "18272264",
            "pub_year": 2008,
            "title": "Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers",
            "volume": "26"
        },
        "b0210": {
            "authors": [
                {
                    "first": "Eva",
                    "initial": "E.",
                    "last": "Van Braeckel"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Bourguignon"
                },
                {
                    "first": "Marguerite",
                    "initial": "M.",
                    "last": "Koutsoukos"
                },
                {
                    "first": "Fr\u00e9d\u00e9ric",
                    "initial": "F.",
                    "last": "Clement"
                },
                {
                    "first": "Michel",
                    "initial": "M.",
                    "last": "Janssens"
                },
                {
                    "first": "Isabelle",
                    "initial": "I.",
                    "last": "Carletti"
                },
                {
                    "first": "Alix",
                    "initial": "A.",
                    "last": "Collard"
                },
                {
                    "first": "Marie Ange",
                    "initial": "M.A.",
                    "last": "Demoiti\u00e9"
                },
                {
                    "first": "Gerald",
                    "initial": "G.",
                    "last": "Voss"
                },
                {
                    "first": "Geert",
                    "initial": "G.",
                    "last": "Leroux-Roels"
                },
                {
                    "first": "Lisa",
                    "initial": "L.",
                    "last": "McNally"
                }
            ],
            "doi": "10.1093/cid/ciq160",
            "firstpage": "522",
            "issn": "10584838",
            "lastpage": "531",
            "pmid": "21208909",
            "pub_year": 2011,
            "title": "An adjuvanted polyprotein HIV-1 vaccine induces polyfunctional cross-reactive CD4+ T cell responses in seronegative volunteers",
            "volume": "52"
        }
    },
    "body_text": [
        {
            "endOffset": 28059,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "These results should be interpreted with caution as there was no adjustment for multiplicity and any clinical relevance is unknown.",
            "startOffset": 27928,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 29793,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "The most frequent solicited general AEs were headache in the 10-10-PLAIN group (overall incidence per subject 40.0%), myalgia in the 10-10-AS01 group (35.5%) and fatigue in the 10-3-AS01 (60.0%) and placebo groups (27.3%) (Fig. 4).",
            "startOffset": 29562,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 24825,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The vaccines were administered intramuscularly.",
            "startOffset": 24778,
            "title": "Study vaccines"
        },
        {
            "endOffset": 26094,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Immunoglobulin G antibody geometric mean concentrations (GMCs) to each vaccine antigen were measured by enzyme-linked immunosorbent assay of blood samples taken before and 30 days after each vaccination, and 5 and 12 months after the second dose.",
            "startOffset": 25848,
            "title": "Humoral and cellular immunogenicity"
        },
        {
            "endOffset": 34067,
            "parents": [],
            "secId": "s0060",
            "sentence": "However, the results show all NTHi-Mcat vaccine formulations had acceptable safety and reactogenicity profiles, including the adjuvanted formulations administered to current or former smokers.",
            "startOffset": 33875,
            "title": "Discussion"
        },
        {
            "endOffset": 35414,
            "parents": [],
            "refoffsets": {
                "b0190": {
                    "endOffset": 35413,
                    "startOffset": 35409
                }
            },
            "secId": "s0060",
            "sentence": "It has been reported previously that anti-UspA2 antibody concentrations tend to increase with age [38].",
            "startOffset": 35311,
            "title": "Discussion"
        },
        {
            "endOffset": 32776,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Antibody GMC ratios adjusted for baseline concentration showed significantly higher GMCs in the 10-3-AS01 group compared to the 10-10-AS01 group in terms of anti-PD antibody response one month post-dose 2 and anti-PilA antibody response 12 months post-dose 2 (online supplementary Table S1).",
            "startOffset": 32485,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 33548,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "No antigen-specific CD8+ T cell responses were detected in any group (data not shown).",
            "startOffset": 33462,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 19897,
            "parents": [],
            "refoffsets": {
                "b0125": {
                    "endOffset": 19820,
                    "startOffset": 19816
                }
            },
            "secId": "s0005",
            "sentence": "Formulations that included the Adjuvant System AS01, a liposome-based vaccine adjuvant system containing two immunostimulants (3-O-desacyl-4\u2032-monophosphoryl lipid A and the saponin QS-21 [25]) produced the highest humoral and cellular immune responses in older adults.",
            "startOffset": 19629,
            "title": "Introduction"
        },
        {
            "endOffset": 20800,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "This phase I, randomised, observer-blind, placebo-controlled study was conducted in three centres in Belgium between August 2015 and March 2017 (ClinicalTrials.gov identifier: NCT02547974).",
            "startOffset": 20611,
            "title": "Study design and subjects"
        },
        {
            "endOffset": 29292,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "All participants were white (European heritage).",
            "startOffset": 29244,
            "title": "Study population"
        },
        {
            "endOffset": 27104,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Data were pooled from the groups that received placebo in step 1 and step 2.",
            "startOffset": 27028,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 29243,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Most participants (73%) were female in the 10-10-PLAIN group, while 42% and 43% were female in the 10-10-AS01 and 10-3-AS01 groups, respectively (Table 1).",
            "startOffset": 29088,
            "title": "Study population"
        },
        {
            "endOffset": 33756,
            "parents": [],
            "secId": "s0060",
            "sentence": "This is the first report of the safety, reactogenicity and immunogenicity of an investigational vaccine containing both NTHi and Mcat surface proteins administered in a two-dose schedule to adults.",
            "startOffset": 33559,
            "title": "Discussion"
        },
        {
            "endOffset": 32484,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "The 10-3-AS01 formulation tended to induce higher or similar humoral responses in comparison to the 10-10-AS01 formulation against each NTHi antigen at all time points.",
            "startOffset": 32316,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 32101,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "No grade 3 or 4 laboratory abnormalities were observed during the study, apart from one grade 3 change in haemoglobin level in the placebo group.",
            "startOffset": 31956,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 25163,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "AE intensity was graded on a 0\u20133 scale.",
            "startOffset": 25124,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 18912,
            "parents": [],
            "refoffsets": {
                "b0075": {
                    "endOffset": 18765,
                    "startOffset": 18761
                },
                "b0080": {
                    "endOffset": 18871,
                    "startOffset": 18867
                },
                "b0085": {
                    "endOffset": 18911,
                    "startOffset": 18904
                },
                "b0090": {
                    "endOffset": 18911,
                    "startOffset": 18904
                }
            },
            "secId": "s0005",
            "sentence": "PD is a highly conserved surface lipoprotein [15], while PE is an adhesin involved in direct interactions with lung epithelial cells and host proteins [16] and human complement resistance [17,18].",
            "startOffset": 18716,
            "title": "Introduction"
        },
        {
            "endOffset": 32868,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Anti-UspA2 antibody GMCs at baseline were relatively high in all groups (384.1\u2013572.5 EU/mL).",
            "startOffset": 32776,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 22860,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "All study inclusion and exclusion criteria are provided in the online supplementary methods.",
            "startOffset": 22768,
            "title": "Study design and subjects"
        },
        {
            "endOffset": 23267,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice.",
            "startOffset": 23169,
            "title": "Study design and subjects"
        },
        {
            "endOffset": 23527,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Three formulations of investigational NTHi-Mcat vaccine were assessed:",
            "startOffset": 23457,
            "title": "Study vaccines"
        },
        {
            "endOffset": 22497,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "In step 1, 30 healthy adults aged 18\u201340 years received a non-adjuvanted vaccine formulation containing 10 \u00b5g of each NTHi antigen and 10 \u00b5g of UspA2 antigen per dose (10-10-PLAIN) or placebo (Fig. 2).",
            "startOffset": 22297,
            "title": "Study design and subjects"
        },
        {
            "endOffset": 31857,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "The subject had a medical history of left-sided facial nerve paralysis of unknown cause approximately 10 years before this event.",
            "startOffset": 31728,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 22296,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "As this was the first time the Mcat UspA2 antigen was to be administered to humans, participants were enrolled in a staggered manner in two steps, with advancement to step 2 or second dose administration dependent on acceptable safety data during the week after administration of the previous dose, as determined by an internal safety review committee.",
            "startOffset": 21944,
            "title": "Study design and subjects"
        },
        {
            "endOffset": 34822,
            "parents": [],
            "secId": "s0060",
            "sentence": "Most reported solicited AEs were mild to moderate in intensity and any grade 3 events were transient.",
            "startOffset": 34721,
            "title": "Discussion"
        },
        {
            "endOffset": 36143,
            "parents": [],
            "refoffsets": {
                "b0120": {
                    "endOffset": 35957,
                    "startOffset": 35953
                },
                "b0130": {
                    "endOffset": 36142,
                    "startOffset": 36135
                },
                "b0135": {
                    "endOffset": 36142,
                    "startOffset": 36135
                },
                "b0140": {
                    "endOffset": 36142,
                    "startOffset": 36135
                },
                "b0195": {
                    "endOffset": 36032,
                    "startOffset": 36028
                }
            },
            "secId": "s0060",
            "sentence": "A low CMI response was also noted for NTHi antigens in the previous study of smokers/ex-smokers [24] and may be due to age-related immunosenescence among the older adults [39] as well as smoking status, since cigarette smoking can stimulate dysregulation of the immune response [26\u201328].",
            "startOffset": 35857,
            "title": "Discussion"
        },
        {
            "endOffset": 17943,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 17942,
                    "startOffset": 17938
                }
            },
            "secId": "s0005",
            "sentence": "There is evidence that NTHi and Mcat are co-pathogens in respiratory tract infections and COPD [11].",
            "startOffset": 17843,
            "title": "Introduction"
        },
        {
            "endOffset": 37007,
            "parents": [],
            "secId": "s0060",
            "sentence": "Clinical studies will assess the effectiveness of the NTHi-Mcat vaccine in reducing the frequency of acute exacerbations in patients with COPD.",
            "startOffset": 36864,
            "title": "Discussion"
        },
        {
            "endOffset": 20084,
            "parents": [],
            "secId": "s0005",
            "sentence": "We conducted a phase I study to evaluate the safety, reactogenicity and immunogenicity of a two-dose schedule of different formulations of the investigational NTHi-Mcat vaccine in adults.",
            "startOffset": 19897,
            "title": "Introduction"
        },
        {
            "endOffset": 21794,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Due to differences in the appearance of the study vaccine and placebo formulation, the study was conducted in an observer-blind manner, i.e. vaccine recipients and those responsible for the evaluation of any study endpoint were blinded to the administered vaccines, although cell-mediated immune (CMI) response analyses could be unblinded.",
            "startOffset": 21455,
            "title": "Study design and subjects"
        },
        {
            "endOffset": 27682,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The immunogenicity analysis was performed on the according-to-protocol (ATP) cohort for immunogenicity, including eligible adults who received the study vaccine as specified in the protocol and complied with study procedures.",
            "startOffset": 27457,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 35633,
            "parents": [],
            "secId": "s0060",
            "sentence": "The CMI response results must be interpreted with caution due to the small number of subjects included in the investigation and high individual variability in number of specific T cells for all antigens and time points.",
            "startOffset": 35414,
            "title": "Discussion"
        },
        {
            "endOffset": 20575,
            "parents": [],
            "secId": "s0005",
            "sentence": "A Focus on the Patient section (Fig. 1) summarises the clinical relevance and impact of this study on the patient population.",
            "startOffset": 20450,
            "title": "Introduction"
        },
        {
            "endOffset": 30646,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "All grade 3 solicited AEs were transient, lasting no longer than 2 days, and resolved spontaneously.",
            "startOffset": 30546,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 28351,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Intracellular cytokine staining data were expressed as frequency of CD4+ and CD8+ T cells expressing cytokines (number/106 CD4+/CD8+ T cells).",
            "startOffset": 28209,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 17324,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 17323,
                    "startOffset": 17320
                }
            },
            "secId": "s0005",
            "sentence": "Acquisition of new bacterial strains is believed to be an important cause of acute exacerbations of COPD (AECOPD) [6].",
            "startOffset": 17206,
            "title": "Introduction"
        },
        {
            "endOffset": 18096,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 18095,
                    "startOffset": 18091
                }
            },
            "secId": "s0005",
            "sentence": "Complement resistance factors present on outer membrane vesicles produced by Mcat appear to protect NTHi from complement-mediated killing in vitro [12].",
            "startOffset": 17944,
            "title": "Introduction"
        },
        {
            "endOffset": 27927,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The two adjuvanted vaccine groups were considered significantly different if the 95% CI for the antibody GMC ratio (adjusted for baseline concentration) between the groups did not contain the value 1.",
            "startOffset": 27727,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 26136,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Sera were stored at \u221220 \u00b0C until assayed.",
            "startOffset": 26095,
            "title": "Humoral and cellular immunogenicity"
        },
        {
            "endOffset": 29088,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Three participants were excluded from the ATP cohort for immunogenicity for reasons shown in Fig. 3 and 119 completed the study (one consent withdrawal not due to AE in 10-10-PLAIN group; also excluded from ATP cohort).",
            "startOffset": 28869,
            "title": "Study population"
        },
        {
            "endOffset": 27337,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The safety analysis was performed on the total vaccinated cohort, including all vaccinated participants.",
            "startOffset": 27233,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 26314,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Blood samples for CMI response analysis were taken before vaccination, 30 days and 5 and 12 months post-dose 2 in a sub-cohort of subjects at step 2 (50% of subjects per group).",
            "startOffset": 26137,
            "title": "Humoral and cellular immunogenicity"
        },
        {
            "endOffset": 34421,
            "parents": [],
            "secId": "s0060",
            "sentence": "Additionally, incidences of solicited local or general AEs following the first dose were similar to those following the second dose across all vaccine formulations.",
            "startOffset": 34257,
            "title": "Discussion"
        },
        {
            "endOffset": 26540,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0165": {
                    "endOffset": 26539,
                    "startOffset": 26535
                }
            },
            "secId": "s0030",
            "sentence": "CMI responses (antigen-specific CD4+ and CD8+ T cells) were measured by flow cytometry using intracellular cytokine staining on peripheral blood mononuclear cells, following an adaptation of previously described methods [33].",
            "startOffset": 26315,
            "title": "Humoral and cellular immunogenicity"
        },
        {
            "endOffset": 32315,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "GMCs for anti-PD, anti-PE and anti-PilA antibodies increased one month after each adjuvanted vaccine dose and waned 5 and 12 months after the second dose but remained higher than baseline (Fig. 5).",
            "startOffset": 32118,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 22767,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "In step 2, 90 adults aged 50\u201370 years with a smoking history of at least 10 pack-years received an AS01-adjuvanted formulation, containing either 10 \u00b5g of each antigen per dose (10-10-AS01) or 10 \u00b5g of each NTHi antigen and 3.3 \u00b5g of Mcat UspA2 (10-3-AS01), or placebo.",
            "startOffset": 22498,
            "title": "Study design and subjects"
        },
        {
            "endOffset": 31314,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Two pIMDs were reported.",
            "startOffset": 31290,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 33066,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "There was a transient increase in anti-UspA2 antibody GMCs after each vaccination, which peaked 30 days after dose 2, with comparable responses among active dose groups at each time point (Fig. 5).",
            "startOffset": 32869,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 24289,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "In animal models, inclusion of UspA2 in the investigational vaccine did not have any relevant impact on the immune response to the NTHi antigens (unpublished data).",
            "startOffset": 24125,
            "title": "Study vaccines"
        },
        {
            "endOffset": 28868,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Forty-four adults (15 at step 1 and 29 at step 2) were enrolled in the placebo control group.",
            "startOffset": 28775,
            "title": "Study population"
        },
        {
            "endOffset": 17843,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 17796,
                    "startOffset": 17793
                },
                "b0050": {
                    "endOffset": 17842,
                    "startOffset": 17838
                }
            },
            "secId": "s0005",
            "sentence": "No vaccine is indicated for the prevention of AECOPD, although influenza and pneumococcal vaccines, which are routinely recommended to COPD patients [3], may have some effect on their frequency [10].",
            "startOffset": 17644,
            "title": "Introduction"
        },
        {
            "endOffset": 19223,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 19180,
                    "startOffset": 19173
                },
                "b0105": {
                    "endOffset": 19180,
                    "startOffset": 19173
                },
                "b0110": {
                    "endOffset": 19222,
                    "startOffset": 19218
                }
            },
            "secId": "s0005",
            "sentence": "UspA2 is a putative autotransporter macromolecule and vitronectin-binding protein involved in mediating Mcat serum resistance [20,21] as well as epithelial cell adherence [22].",
            "startOffset": 19047,
            "title": "Introduction"
        },
        {
            "endOffset": 31956,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Both pIMDs were considered by the investigator as non-serious and causally related to vaccination.",
            "startOffset": 31858,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 33461,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "There was high variability in the number of specific CD4+ T cells for each vaccine antigen at each time point and CD4+ T cell responses were low.",
            "startOffset": 33316,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 33874,
            "parents": [],
            "secId": "s0060",
            "sentence": "Since a limited number of participants was enrolled, no formal statistical comparisons between groups were performed.",
            "startOffset": 33757,
            "title": "Discussion"
        },
        {
            "endOffset": 34971,
            "parents": [],
            "refoffsets": {
                "b0120": {
                    "endOffset": 34970,
                    "startOffset": 34966
                }
            },
            "secId": "s0060",
            "sentence": "Humoral immune responses to the NTHi antigens were comparable to those observed in the previous study of the NTHi vaccine in smokers/ex-smokers [24].",
            "startOffset": 34822,
            "title": "Discussion"
        },
        {
            "endOffset": 18715,
            "parents": [],
            "secId": "s0005",
            "sentence": "Three conserved proteins were selected from NTHi, a free recombinant protein D (PD) and a recombinant fusion protein combining protein E and Pilin A (PE-PilA), and the fourth from Mcat, ubiquitous surface protein A2 (UspA2).",
            "startOffset": 18491,
            "title": "Introduction"
        },
        {
            "endOffset": 20968,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Participants were randomised, using a blocking scheme (1:1 ratio at step 1 and 1:1:1 ratio at step 2), to receive two vaccine formulation doses 60 days apart (Fig. 2).",
            "startOffset": 20801,
            "title": "Study design and subjects"
        },
        {
            "endOffset": 27456,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The incidence of AEs per study group was calculated with exact 95% confidence intervals (CIs) after each vaccine dose.",
            "startOffset": 27338,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 34256,
            "parents": [],
            "refoffsets": {
                "b0120": {
                    "endOffset": 34255,
                    "startOffset": 34251
                }
            },
            "secId": "s0060",
            "sentence": "This was in line with observations with an NTHi investigational vaccine containing the same NTHi antigen doses and AS01E, when administered to older smokers/ex-smokers of similar age [24].",
            "startOffset": 34068,
            "title": "Discussion"
        },
        {
            "endOffset": 18222,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 18221,
                    "startOffset": 18214
                },
                "b0070": {
                    "endOffset": 18221,
                    "startOffset": 18214
                }
            },
            "secId": "s0005",
            "sentence": "Co-infection with NTHi and Mcat also promotes the increased resistance of biofilms to antibiotics and host clearance [13,14].",
            "startOffset": 18097,
            "title": "Introduction"
        },
        {
            "endOffset": 35125,
            "parents": [],
            "secId": "s0060",
            "sentence": "The adjuvanted vaccine formulations induced persistent specific immune responses against the NTHi antigens up to 12 months after the second vaccine dose.",
            "startOffset": 34972,
            "title": "Discussion"
        },
        {
            "endOffset": 28774,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "One hundred and twenty adults were enrolled and vaccinated; 15 healthy adults aged 20\u201340 years (mean 29 years) were vaccinated with non-adjuvanted NTHi-Mcat vaccine at step 1 and 61 current or former smokers aged 50\u201371 years (mean 59 years) with an adjuvanted NTHi-Mcat vaccine formulation at step 2 (Table 1).",
            "startOffset": 28464,
            "title": "Study population"
        },
        {
            "endOffset": 23884,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 23883,
                    "startOffset": 23879
                }
            },
            "secId": "s0020",
            "sentence": "The NTHi antigens and AS01E were described previously [24].",
            "startOffset": 23825,
            "title": "Study vaccines"
        },
        {
            "endOffset": 30148,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "There was one report of grade 3 pain after the first dose in the 10-10-AS01 group and one after the second dose in the 10-3-AS01 group.",
            "startOffset": 30013,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 29561,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Pain was the most frequent solicited local AE during the 7-day post-vaccination period, with overall incidences per subject of 46.7%, 80.6%, 93.3% and 25.0% in the 10-10-PLAIN, 10-10-AS01, 10-3-AS01 and placebo groups, respectively (Fig. 4).",
            "startOffset": 29320,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 33315,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Evaluation of the frequency of antigen-specific CD4+ T cells expressing at least two markers among CD40L, IL-2, TNF-\u03b1, IFN-\u0263, IL-13 and IL-17 showed increases from baseline up to one month after the second adjuvanted NTHi-Mcat vaccine dose (Fig. 6).",
            "startOffset": 33066,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 20450,
            "parents": [],
            "refoffsets": {
                "b0120": {
                    "endOffset": 20330,
                    "startOffset": 20326
                }
            },
            "secId": "s0005",
            "sentence": "Therefore, as in one of the previous phase I studies of the NTHi protein vaccine [24], we recruited adults with a smoking history of at least 10 pack-years to immunologically represent the COPD population.",
            "startOffset": 20245,
            "title": "Introduction"
        },
        {
            "endOffset": 19628,
            "parents": [],
            "refoffsets": {
                "b0120": {
                    "endOffset": 19627,
                    "startOffset": 19623
                }
            },
            "secId": "s0005",
            "sentence": "The NTHi proteins had an acceptable safety and reactogenicity profile and induced antigen-specific immune responses in phase I studies in current and former smokers aged 50\u201370 years and healthy 18\u201340 year-olds [24].",
            "startOffset": 19413,
            "title": "Introduction"
        },
        {
            "endOffset": 24778,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0145": {
                    "endOffset": 24777,
                    "startOffset": 24773
                }
            },
            "secId": "s0020",
            "sentence": "The 3.3 \u00b5g UspA2 dose used in the 10-3-AS01 formulation of the study vaccine was selected due to the detection of natural anti-UspA2 antibodies in a high proportion of adults, including COPD patients [29].",
            "startOffset": 24573,
            "title": "Study vaccines"
        },
        {
            "endOffset": 25684,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0160": {
                    "endOffset": 25683,
                    "startOffset": 25679
                }
            },
            "secId": "s0025",
            "sentence": "Haematological and biochemical parameters, measured at screening, before and 7 days after each vaccination, and 5 and 12 months after the second dose, were graded 0\u20134 [32].",
            "startOffset": 25512,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 27027,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The probability of detecting an AE, assuming a Poisson model and true incidence of 5%, was 78.5% with 30 participants per group in step 2.",
            "startOffset": 26889,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 25512,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0155": {
                    "endOffset": 25452,
                    "startOffset": 25448
                }
            },
            "secId": "s0025",
            "sentence": "Data on potential immune-mediated diseases (pIMDs; including autoimmune and other inflammatory or neurologic disorders of interest) [31] and serious AEs (SAEs) were collected throughout the study.",
            "startOffset": 25316,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 28208,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The frequency of specific CD4+ and CD8+ T cells expressing at least two cytokine markers was summarised by study group using descriptive statistics.",
            "startOffset": 28060,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 31502,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Dermatomyositis, diagnosed by skin biopsy, was reported in a 28-year-old subject in the 10-10-PLAIN group, with onset at Day 177 post-dose 2, that did not resolve by the end of the study.",
            "startOffset": 31315,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 36522,
            "parents": [],
            "secId": "s0060",
            "sentence": "In conclusion, this phase I study demonstrated that the investigational NTHi-Mcat vaccine formulations have acceptable safety, reactogenicity and immunogenicity in older adults with a smoking history of at least 10 pack-years.",
            "startOffset": 36296,
            "title": "Discussion"
        },
        {
            "endOffset": 27232,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Since this phase I study enrolled a limited number of subjects, no formal statistical comparisons between groups were conducted.",
            "startOffset": 27104,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 26888,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "As this was a first-time-in-humans study for the Mcat UspA2 antigen and the primary objective was safety, sample size was not powered to demonstrate any hypothesis.",
            "startOffset": 26724,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 19413,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 19360,
                    "startOffset": 19356
                }
            },
            "secId": "s0005",
            "sentence": "Anti-UspA2 antibodies significantly reduced the lung bacterial load in mice challenged with homologous or heterologous Mcat strains [23], suggesting UspA2 can induce broad cross protection.",
            "startOffset": 19224,
            "title": "Introduction"
        },
        {
            "endOffset": 24124,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The UspA2 protein was produced by fermentation of the recombinant E. coli, followed by protein purification and sterile filtration.",
            "startOffset": 23993,
            "title": "Study vaccines"
        },
        {
            "endOffset": 27726,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Antibody GMCs were determined with 95% CIs.",
            "startOffset": 27683,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 30908,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "During the 30-day post-vaccination period, at least one unsolicited AE was reported by 53.3%, 64.5%, 60.0% and 65.9% of participants in the 10-10-PLAIN, 10-10-AS01, 10-3-AS01 and placebo groups, respectively, most commonly nasopharyngitis and headache (Table 2).",
            "startOffset": 30646,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 23992,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The recombinant Escherichia coli BLR (DE3) B2690-Rix4517 strain was used to express the Mcat UspA2 protein.",
            "startOffset": 23885,
            "title": "Study vaccines"
        },
        {
            "endOffset": 25315,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Grade 3 intensity was defined as redness or swelling of diameter >100 mm, temperature >39.5 \u00b0C and, for all other AEs, prevention of normal activities.",
            "startOffset": 25164,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 17206,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 17125,
                    "startOffset": 17122
                },
                "b0025": {
                    "endOffset": 17205,
                    "startOffset": 17202
                }
            },
            "secId": "s0005",
            "sentence": "Its course is characterised by exacerbations of respiratory symptoms, which increase the morbidity and mortality associated with the disease [4] and account for a significant proportion (40\u201360%) of medical costs for COPD [5].",
            "startOffset": 16981,
            "title": "Introduction"
        },
        {
            "endOffset": 21454,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Treatment was allocated at each site via a central randomisation system (SBIR), using a minimisation algorithm accounting for centre at step 1 and age category (50\u201359 or 60\u201370 years), smoking status (current or former smoker) and forced expiratory volume in 1 s/forced vital capacity ratio (\u22650.7 or <0.7) at step 2.",
            "startOffset": 21139,
            "title": "Study design and subjects"
        },
        {
            "endOffset": 23608,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "10-10-Plain: containing 10 \u00b5g PD, 10 \u00b5g PE-PilA (fusion protein) and 10 \u00b5g UspA2",
            "startOffset": 23528,
            "title": "Study vaccines"
        },
        {
            "endOffset": 31289,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "During the entire study, two participants in the active vaccine groups reported four SAEs (gastroenteritis in one subject in 10-10-PLAIN group; pneumonia, rib fracture and nasal septum deviation in one subject in 10-3-AS01 group) and two in the placebo group reported two SAEs (inguinal hernia and ankle fracture), none of which were considered as causally related to vaccination.",
            "startOffset": 30909,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 34720,
            "parents": [],
            "refoffsets": {
                "b0120": {
                    "endOffset": 34538,
                    "startOffset": 34528
                },
                "b0170": {
                    "endOffset": 34538,
                    "startOffset": 34528
                },
                "b0175": {
                    "endOffset": 34538,
                    "startOffset": 34528
                },
                "b0180": {
                    "endOffset": 34538,
                    "startOffset": 34528
                },
                "b0185": {
                    "endOffset": 34719,
                    "startOffset": 34715
                }
            },
            "secId": "s0060",
            "sentence": "As expected from other studies that compared adjuvanted vaccines to non-adjuvanted formulations or placebo [24,34\u201336], reactogenicity was highest in the adjuvanted NTHi-Mcat vaccine groups, which may be related to more intense activation of the innate immune response by AS-adjuvanted vaccines [37].",
            "startOffset": 34421,
            "title": "Discussion"
        },
        {
            "endOffset": 23440,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "All participants provided written informed consent before study entry.",
            "startOffset": 23370,
            "title": "Study design and subjects"
        },
        {
            "endOffset": 23825,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "10-3-AS01: containing 10 \u00b5g PD, 10 \u00b5g PE-PilA (fusion protein) and 3.3 \u00b5g UspA2, with adjuvantation (AS01E).",
            "startOffset": 23717,
            "title": "Study vaccines"
        },
        {
            "endOffset": 25123,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Solicited local (pain, redness and swelling at the injection site) and general (fatigue, gastrointestinal symptoms, headache, myalgia and fever) adverse events (AEs) were recorded for 7 days after each dose and unsolicited AEs for 30 days after each dose on diary cards.",
            "startOffset": 24853,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 30295,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "There were seven reports of grade 3 general solicited AEs, two of which were in the 10-10-PLAIN group (fatigue and headache after the first dose).",
            "startOffset": 30149,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 21944,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Vaccines were prepared and administered by authorised medical personnel who did not participate in any of the study\u2019s clinical evaluations or assays.",
            "startOffset": 21795,
            "title": "Study design and subjects"
        },
        {
            "endOffset": 30545,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "The remaining five reports were in the adjuvanted NTHi-Mcat vaccine groups (one report of headache after first 10-3-AS01 dose and one headache [10-10-AS01], one fatigue [10-3-AS01] and two myalgia cases [10-10-AS01 and 10-3-AS01] after second dose).",
            "startOffset": 30296,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 35856,
            "parents": [],
            "secId": "s0060",
            "sentence": "Antigen-specific CMI responses one month after the second dose, in terms of CD4+ T cells expressing at least two markers, tended to be higher in the adjuvanted vaccine groups than with placebo, although responses were low.",
            "startOffset": 35634,
            "title": "Discussion"
        },
        {
            "endOffset": 28437,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Statistical analyses were performed using SAS version 9.3 on SAS Drug Development 4.3.",
            "startOffset": 28351,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 36863,
            "parents": [],
            "refoffsets": {
                "b0120": {
                    "endOffset": 36862,
                    "startOffset": 36858
                }
            },
            "secId": "s0060",
            "sentence": "The formulation containing 10 \u00b5g NTHi and 3.3 \u00b5g Mcat antigen doses has been selected for further investigation, taking into consideration summary scores derived from the immune response data (see online supplementary methods) and adjusted GMC ratios from the present study, together with results with the investigational NTHi vaccine [24].",
            "startOffset": 36523,
            "title": "Discussion"
        },
        {
            "endOffset": 17643,
            "parents": [],
            "secId": "s0005",
            "sentence": "Vaccination to reduce the frequency of AECOPD caused by bacteria may therefore be beneficial.",
            "startOffset": 17550,
            "title": "Introduction"
        },
        {
            "endOffset": 23369,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The protocols and associated documents were reviewed and approved by an independent ethics committee.",
            "startOffset": 23268,
            "title": "Study design and subjects"
        },
        {
            "endOffset": 35310,
            "parents": [],
            "secId": "s0060",
            "sentence": "There was a moderate and transient specific response against the Mcat antigen, which may have been due to the relatively high concentration of anti-UspA2 antibodies before vaccination.",
            "startOffset": 35126,
            "title": "Discussion"
        },
        {
            "endOffset": 20244,
            "parents": [],
            "refoffsets": {
                "b0130": {
                    "endOffset": 20243,
                    "startOffset": 20236
                },
                "b0135": {
                    "endOffset": 20243,
                    "startOffset": 20236
                },
                "b0140": {
                    "endOffset": 20243,
                    "startOffset": 20236
                }
            },
            "secId": "s0005",
            "sentence": "Cigarette smoking is the most commonly encountered risk factor for COPD and evidence suggests it can alter the immune system before COPD is recognised [26\u201328].",
            "startOffset": 20085,
            "title": "Introduction"
        },
        {
            "endOffset": 25810,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Abnormal laboratory findings that were judged by the investigator to be clinically significant were recorded as an AE or SAE.",
            "startOffset": 25685,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 21138,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The two randomisation lists were generated at GSK using MATerial Excellence (MATEX), a program developed by GSK for use with Statistical Analysis Systems (SAS) software.",
            "startOffset": 20969,
            "title": "Study design and subjects"
        },
        {
            "endOffset": 36296,
            "parents": [],
            "refoffsets": {
                "b0120": {
                    "endOffset": 36295,
                    "startOffset": 36282
                },
                "b0185": {
                    "endOffset": 36295,
                    "startOffset": 36282
                },
                "b0200": {
                    "endOffset": 36295,
                    "startOffset": 36282
                },
                "b0205": {
                    "endOffset": 36295,
                    "startOffset": 36282
                },
                "b0210": {
                    "endOffset": 36295,
                    "startOffset": 36282
                }
            },
            "secId": "s0060",
            "sentence": "CD8+ T cell induction was not detected, which was consistent with other studies of AS01-adjuvanted recombinant protein vaccines in adults [24,37,40\u201342].",
            "startOffset": 36144,
            "title": "Discussion"
        },
        {
            "endOffset": 23168,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The primary objective was to assess the safety and reactogenicity of the investigational NTHi-Mcat vaccine formulations and the secondary objective was to describe their humoral and cellular immunogenicity after vaccination and persistence of immune responses up to 12 months after the second dose (Day 420).",
            "startOffset": 22860,
            "title": "Study design and subjects"
        },
        {
            "endOffset": 17549,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 17548,
                    "startOffset": 17543
                },
                "b0040": {
                    "endOffset": 17548,
                    "startOffset": 17543
                },
                "b0045": {
                    "endOffset": 17548,
                    "startOffset": 17543
                }
            },
            "secId": "s0005",
            "sentence": "Although estimates vary widely, non-typeable Haemophilus influenzae (NTHi) appears to be the main bacterial pathogen associated with exacerbations, followed by Moraxella catarrhalis (Mcat) and Streptococcus pneumoniae [7\u20139].",
            "startOffset": 17325,
            "title": "Introduction"
        },
        {
            "endOffset": 26701,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The frequency of antigen-specific CD4+ and CD8+ T cells expressing at least two cytokine markers among CD40L, IL-2, TNF-\u03b1, IFN-\u0263, IL-13 or IL-17 was calculated.",
            "startOffset": 26541,
            "title": "Humoral and cellular immunogenicity"
        },
        {
            "endOffset": 16980,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 16835,
                    "startOffset": 16830
                },
                "b0010": {
                    "endOffset": 16835,
                    "startOffset": 16830
                },
                "b0015": {
                    "endOffset": 16979,
                    "startOffset": 16976
                }
            },
            "secId": "s0005",
            "sentence": "Chronic obstructive pulmonary disease (COPD) is a debilitating, progressive disease with a global prevalence around 10\u201312% among older adults [1,2], which is likely to increase because of population aging and continued exposure to the main risk factors, cigarette smoke and air pollution [3].",
            "startOffset": 16688,
            "title": "Introduction"
        },
        {
            "endOffset": 24573,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0145": {
                    "endOffset": 24572,
                    "startOffset": 24565
                },
                "b0150": {
                    "endOffset": 24572,
                    "startOffset": 24565
                }
            },
            "secId": "s0020",
            "sentence": "The 10 \u00b5g UspA2 dose used in the 10-10-Plain and 10-10-AS01 formulations of the study vaccine was selected as it was the same dose selected for the NTHi antigens based on the results of phase I clinical trials, where no antigen-dose effect was observed for the NTHi antigens [29,30].",
            "startOffset": 24290,
            "title": "Study vaccines"
        },
        {
            "endOffset": 30012,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "After each dose and overall per subject, incidences of individual solicited local AEs were higher in the groups who received adjuvanted NTHi-Mcat vaccine than those who received unadjuvanted vaccine or placebo (Fig. 4).",
            "startOffset": 29793,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 18490,
            "parents": [],
            "secId": "s0005",
            "sentence": "An investigational adjuvanted multi-component vaccine has been developed to potentially reduce the frequency of moderate and severe AECOPD associated with NTHi and Mcat, containing four surface proteins involved in the virulence mechanisms of both bacterial pathogens.",
            "startOffset": 18222,
            "title": "Introduction"
        },
        {
            "endOffset": 19046,
            "parents": [],
            "refoffsets": {
                "b0095": {
                    "endOffset": 19045,
                    "startOffset": 19041
                }
            },
            "secId": "s0005",
            "sentence": "PilA plays a key role in biofilm formation, adherence to human epithelial cells and colonisation of the upper respiratory tract [19].",
            "startOffset": 18913,
            "title": "Introduction"
        },
        {
            "endOffset": 23716,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "10-10-AS01: containing 10 \u00b5g PD, 10 \u00b5g PE-PilA (fusion protein) and 10 \u00b5g UspA2, with adjuvantation (AS01E)",
            "startOffset": 23609,
            "title": "Study vaccines"
        },
        {
            "endOffset": 31727,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Trigeminal neuralgia (left upper cheek) was reported in a 60-year-old subject in the 10-3-AS01 group, with symptom onset 63 days after the first dose, before receiving the second dose, which resolved by the end of the study.",
            "startOffset": 31503,
            "title": "Safety and reactogenicity"
        }
    ],
    "docId": "S0264410X19305055",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Pierre",
                "initial": "P.",
                "last": "Van Damme"
            },
            {
                "email": null,
                "first": "Geert",
                "initial": "G.",
                "last": "Leroux-Roels"
            },
            {
                "email": null,
                "first": "Corinne",
                "initial": "C.",
                "last": "Vandermeulen"
            },
            {
                "email": null,
                "first": "Iris",
                "initial": "I.",
                "last": "De Ryck"
            },
            {
                "email": null,
                "first": "Annaelisa",
                "initial": "A.",
                "last": "Tasciotti"
            },
            {
                "email": null,
                "first": "Marie",
                "initial": "M.",
                "last": "Dozot"
            },
            {
                "email": null,
                "first": "Luca",
                "initial": "L.",
                "last": "Moraschini"
            },
            {
                "email": "marco.x.testa@gsk.com",
                "first": "Marco",
                "initial": "M.",
                "last": "Testa"
            },
            {
                "email": null,
                "first": "Ashwani Kumar",
                "initial": "A.K.",
                "last": "Arora"
            }
        ],
        "doi": "10.1016/j.vaccine.2019.04.041",
        "firstpage": "3113",
        "issn": "0264410X",
        "keywords": [
            "Acute exacerbation",
            "COPD",
            "Clinical trial",
            "Haemophilus influenzae",
            "Moraxella catarrhalis"
        ],
        "lastpage": "3122",
        "openaccess": "Full",
        "pub_year": 2019,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Safety and immunogenicity of non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine"
    }
}